Upgrade to SI Premium - Free Trial

Silo Pharma, Inc. (SILO)

6.12 +0.31 (5.34%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/2/26)

Latest Headlines

Form 8-K Silo Pharma, Inc. For: Jun 17 June 18, 2026 5:16 PM - SEC Filing Form PRE 14A Silo Pharma, Inc. For: Aug 14 June 18, 2026 5:12 PM - SEC Filing Silo Pharma regains Nasdaq minimum bid price compliance June 18, 2026 8:12 AM - StreetInsider Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement June 18, 2026 8:12 AM - StreetInsider Form 8-K Silo Pharma, Inc. For: Jun 01 June 3, 2026 5:01 PM - SEC Filing Form 8-K Silo Pharma, Inc. For: Jun 01 June 1, 2026 9:02 AM - SEC Filing Form 10-Q Silo Pharma, Inc. For: Mar 31 May 14, 2026 6:05 AM - SEC Filing Silo Pharma files patent for ibogaine treatment targeting brain injury May 7, 2026 8:06 AM - StreetInsider Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury May 7, 2026 8:05 AM - StreetInsider Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury May 7, 2026 8:05 AM - Globe NewsWire Silo Pharma comments on federal psychedelic therapy initiatives April 29, 2026 9:08 AM - StreetInsider Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD April 29, 2026 9:08 AM - Globe NewsWire Silo Pharma acquires AI platform Qwikagents to expand into AI agent market April 22, 2026 4:15 PM - StreetInsider Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents April 22, 2026 4:15 PM - StreetInsider Silo Pharma highlights PTSD treatment amid Trump psychedelic order April 20, 2026 6:34 AM - StreetInsider Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics April 20, 2026 6:34 AM - StreetInsider Silo Pharma highlights PTSD treatment amid Trump psychedelics order April 20, 2026 6:34 AM - StreetInsider Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics April 20, 2026 6:34 AM - Globe NewsWire Form 424B3 Silo Pharma, Inc. April 16, 2026 4:16 PM - SEC Filing Form EFFECT Silo Pharma, Inc. April 16, 2026 6:05 AM - SEC Filing Form 424B3 Silo Pharma, Inc. April 14, 2026 5:11 PM - SEC Filing Form POS AM Silo Pharma, Inc. April 14, 2026 4:39 PM - SEC Filing Form EFFECT Silo Pharma, Inc. April 14, 2026 6:03 AM - SEC Filing Form POS AM Silo Pharma, Inc. April 10, 2026 5:30 PM - SEC Filing Silo Pharma receives European patent allowance for PTSD prevention therapy April 6, 2026 4:16 PM - StreetInsider Silo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention Therapy April 6, 2026 4:15 PM - StreetInsider Form 8-K Silo Pharma, Inc. For: Mar 30 April 2, 2026 4:16 PM - SEC Filing Form 10-K Silo Pharma, Inc. For: Dec 31 March 27, 2026 4:40 PM - SEC Filing Full Article List